Design Therapeutics
Biotechnology ResearchView the employees at
Design Therapeutics-
Catherine Livelo Research Associate
-
United States
-
Rising Star
Doane Chilcoat Senior Vice President of Technology and Research at Design Therapeutics-
Rising Star
Alita Miller SVP, Head of Preclinical Development and Translational Medicine-
Carlsbad, California, United States
-
Rising Star
Jhuma Das, Ph.D. Associate Director, Computational Chemistry at Design Therapeutics-
Top 10%
Michael Amadeo Senior Research Associate at Design Therapeutics-
San Diego, California, United States
-
Rising Star
Overview
We are a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC™ gene targeted chimera small molecules. The company’s GeneTAC™ molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. Design’s lead program is focused on the treatment of Friedreich ataxia, followed by programs in Fuchs endothelial corneal dystrophy and myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information, please visit designtx.com.
-